SciPio Bioscience
Versatile and accessible single-cell analysis
Scipio bioscience is an early-stage company that develops innovative solutions for single-cell sample preparation and data analysis to answer the growing needs of basic and clinical research labs. Its patented RevGel™ technology, at the core of the Asteria™ Kit, is an innovative reversible hydrogel conceived by its President and Co-Founder, Prof. Stuart Edelstein, a world-renowned biophysicist. With its R&D laboratories and offices in Paris, France, Scipio bioscience is supported by government funding and receives significant private investment from Seventure, M Ventures, High-Tech Gründerfonds, Financière Arbevel and Verve Ventures.
